Tirzepatide significantly reduces predicted risk of ASCVD among patients with obesity without diabetes Niveditha Subramani13 Nov 2023 10:00 AM ISTThe results of the phase 3 trial reveal that tirzepatide treatment over 72 weeks significantly reduced the 10-year predicted risk of ASCVD versus...
The BMJ study examines long-term effectiveness of live shingles vaccine Dr. Kamal Kant Kohli13 Nov 2023 9:45 AM ISTThe effectiveness of live zoster (shingles) vaccine is highest in the first year after vaccination and then wanes substantially. But it continues to...
Gender-neutral HPV vaccination best at preventing cervical cancer Isra Zaman13 Nov 2023 9:30 AM ISTThe most effective way to prevent cervical cancer is to give HPV vaccines to both boys and girls, reports a collaborative study involving researchers...
Hydroxyurea effective in management of sickle cell anemia in children Niveditha Subramani13 Nov 2023 3:30 AM ISTHydroxyurea is in a popular class of medications called antimetabolites. Hydroxyurea is known treats cancer by slowing or stopping the growth of...
Hydroxychloroquine safe alternative to topical steroids for management of oral lichen planus: Study Medha Baranwal12 Nov 2023 11:30 PM ISTChina: A recent study published in Oral Diseases has revealed hydroxychloroquine to be an effective and safe agent for treating...
Dialyzable leukocyte extract as adjuvant treatment of allergic rhinitis improves QoL of patients Medha Baranwal12 Nov 2023 8:00 PM ISTMexico: Dialyzable leukocyte extract (DLE), a peptide-based immunomodulator, might be a beneficial adjuvant treatment for allergic rhinitis (AR), a...
Trial supports new drug for the treatment of focal-onset seizures Medha Baranwal12 Nov 2023 4:30 PM ISTUSA: A phase 2b randomized clinical trial has shed light on the safety and efficacy of XEN1101 in adults with focal epilepsy. XEN1101 is a novel,...
Semaglutide Does Not Appear to Worsen Diabetic Eye Disease in Most Patients, New Study Suggests Dr. Kamal Kant Kohli11 Nov 2023 10:15 AM ISTEven as use of the diabetes drug semaglutide surged in popularity for its ability to help people lower their glucose levels and better manage their...
Co-existing non-ischemic cardiomyopathy may hamper benefits of revascularization for obstructive CAD: Circulation Medha Baranwal11 Nov 2023 10:00 AM ISTUSA: A recent study has identified non-ischemic cardiomyopathy (NICM) or dual CM in 1 of every 6 patients in those with coronary artery disease (CAD)...
Increasing workplace flexibility associated with lower risk of cardiovascular disease Isra Zaman11 Nov 2023 9:15 AM ISTIncreasing workplace flexibility may lower employees' risk of cardiovascular disease, according to a new study led by Harvard T.H. Chan School of...
Can metformin delay progression of prostate cancer? Study provides insights Dr. Kamal Kant Kohli10 Nov 2023 6:30 PM ISTUSA: A new study from Columbia researchers suggests that metformin is indeed a promising drug that could prevent the progression of prostate cancer,...
First Chikungunya Vaccine gets FDA nod Dr. Kamal Kant Kohli10 Nov 2023 5:07 PM ISTUSA: Ixchiq, the first chikungunya vaccine, has received approval from the U.S. Food and Drug Administration for individuals aged 18 years and above...
